circulating tumor DNA
Liquid Biopsy-Based Colorectal Cancer Screening Lacks Cost-Effectiveness, Economic Analysis Finds
A simulation study suggests colonoscopy remains the most cost-effective CRC screening method, as liquid biopsy carries a far higher price per life-year gained.
NeoGenomics Raises Full-Year Guidance as Q3 Revenues Top Estimates
Third quarter revenue growth was driven by increasing clinical test volumes, a continuing shift to higher-complexity tests, and improvements in revenue per test.
A five-year, $4.6 million NCI grant will help the researchers advance their EFIRM electric field-based DNA detection platform toward potential regulatory approval.
Multimodal Cell-Free DNA Test May Help Detect Cancer Early in Li-Fraumeni Syndrome Patients
Researchers analyzed cfDNA from blood focusing on genomic, fragmentomic, and epigenomic features linked to cancer in individuals with germline TP53 mutations.
In New TRACERx Data, Personalis MRD Test Shows Improved Sensitivity With Potential Clinical Impact
Premium
The data, some of the first available for the firm's NeXT Personal test, indicated that its higher analytical sensitivity could lead to better risk prediction than competing tests.